FindTrial
Sign In

To study the effect of Madhukadi Arka eye drop and olopatadine eye drop in Simple Allergic Conjunctivitis.

A Randomized controlled clinical study to evaluate the efficacy of Madhukadi Arka eye drop and Olopatadine eye drop in Simple Allergic Conjunctivitis. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060594
Enrollment
64
Registered
2023-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

PDEAS College of Ayurveda and Research CentreNigadi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient having minimum three sign and symptoms of all simple allergic conjunctivitis as below, 1.itching 2.watery discharge 3.ricking sensation 4.hyperemia 5.chemosis 6.lid oedema.

Exclusion criteria

Exclusion criteria: 1.known case of congenital anomalies of eye. 2.patient with history of recent ophthalmic surgery upto-1month 3.patient with active eye infections.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Madhukadi arka eye drops in management of Simple Allergic Conjunctivitis within 7 daysTimepoint: 1 drop two times a day for 7 days with follow up on 4th and 8th day.—

Secondary

MeasureTime frame
To study the adverse effect if anyTimepoint: 1 drop two times a day for 7 days with follow up on 4th and 8th day.—

Countries

India

Contacts

Public ContactDr Dhanashri Rajabhau Navale

PDEAS College of Ayurveda and Research Centre,Nigadi

drvirkarchandana@gmail.com9822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026